Literature DB >> 15348112

Preparation of phosphorus-containing silica glass microspheres for radiotherapy of cancer by ion implantation.

M Kawashita1, F Miyaji, T Kokubo, Y Suzuki, K Kajiyama.   

Abstract

A chemically durable glass microsphere containing a large amount of phosphorus is useful for in situ irradiation of cancers, since they can be activated to be a beta-emitter with a half-life of 14.3 d by neutron bombardment. When the activated microspheres are injected to the tumors, they can irradiate the tumors directly with beta-rays without irradiating neighboring normal tissues. In the present study, P+ ion was implanted into silica glass microspheres of 25 microm in average diameter at 50 keV with nominal doses of 2.5 x 10(16) and 3.35 x 10(1)6 cm(-2). The glass microspheres were put into a stainless container and the container was continuously shaken during the ion implantation so that P+ ion was implanted into them uniformly. The implanted phosphorus was localized in deep regions of the glass microsphere with the maximum concentration at about 50 nm depth without distributing up to the surface even for a nominal dose of 3.35 x 10(16) cm(-2). Both samples released phosphorus and silicon into water at 95 degrees C for 7 d. On the basis of the previous study on P+-implanted silica glass plates, the silica glass microspheres containing more phosphorus which is desired for actual treatment could be obtained, without losing high chemical durability, if P+ ion would be implanted at higher energy than 50 keV to be localized in deeper region.

Entities:  

Year:  1999        PMID: 15348112     DOI: 10.1023/a:1008940823818

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  8 in total

1.  Therapeutic use of 90Y microspheres.

Authors:  G J Ehrhardt; D E Day
Journal:  Int J Rad Appl Instrum B       Date:  1987

2.  Effects of hepatic arterial yttrium 90 glass microspheres in dogs.

Authors:  I Wollner; C Knutsen; P Smith; D Prieskorn; C Chrisp; J Andrews; J Juni; S Warber; J Klevering; J Crudup
Journal:  Cancer       Date:  1988-04-01       Impact factor: 6.860

3.  Intraarterial yttrium 90 in the treatment of hepatic malignancy.

Authors:  R V Mantravadi; D G Spigos; W S Tan; E L Felix
Journal:  Radiology       Date:  1982-03       Impact factor: 11.105

4.  Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres.

Authors:  S Houle; T K Yip; F A Shepherd; L E Rotstein; K W Sniderman; E Theis; R H Cawthorn; K Richmond-Cox
Journal:  Radiology       Date:  1989-09       Impact factor: 11.105

5.  Hepatic malignancies: improved treatment with intraarterial Y-90.

Authors:  M J Herba; F F Illescas; M P Thirlwell; G J Boos; L Rosenthall; M Atri; P M Bret
Journal:  Radiology       Date:  1988-11       Impact factor: 11.105

6.  A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma.

Authors:  F A Shepherd; L E Rotstein; S Houle; T C Yip; K Paul; K W Sniderman
Journal:  Cancer       Date:  1992-11-01       Impact factor: 6.860

7.  Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up.

Authors:  J C Andrews; S C Walker; R J Ackermann; L A Cotton; W D Ensminger; B Shapiro
Journal:  J Nucl Med       Date:  1994-10       Impact factor: 10.057

8.  Chemical durability of Y2O3-Al2O3-SiO2 glasses for the in vivo delivery of beta radiation.

Authors:  E M Erbe; D E Day
Journal:  J Biomed Mater Res       Date:  1993-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.